Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 11—November 2020
Research Letter

Large Outbreak of Guillain-Barré Syndrome, Peru, 2019

César V. Munayco, Ronnie G. Gavilan, Gladys Ramirez, Manuel Loayza, Maria L. Miraval, Erin Whitehouse, Radhika Gharpure, Jesus Soares, Hans Vasquez Soplopuco, and James SejvarComments to Author 
Author affiliations: Centro Nacional de Epidemiología Prevención y Control de Enfermedades, Lima, Peru (C.V. Munayco, G. Ramirez, M. Loayza); Instituto Nacional de Salud, Lima (R.G. Gavilan, M.L. Miraval, H.V. Soplopuco); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (E. Whitehouse, R. Gharpure, J. Soares, J. Sejvar)

Main Article

Figure

Cases of Guillain-Barré syndrome classified by Brighton Collaboration criteria (5) and date of illness onset, Peru, May–July 2019.

Figure. Cases of Guillain-Barré syndrome classified by Brighton Collaboration criteria (5) and date of illness onset, Peru, May–July 2019.

Main Article

References
  1. Sejvar  JJ, Baughman  AL, Wise  M, Morgan  OW. Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011;36:123–33. DOIPubMedGoogle Scholar
  2. Ansar  V, Valadi  N. Guillain-Barré syndrome. Prim Care. 2015;42:189–93. DOIPubMedGoogle Scholar
  3. Govoni  V, Granieri  E. Epidemiology of the Guillain-Barré syndrome. Curr Opin Neurol. 2001;14:605–13. DOIPubMedGoogle Scholar
  4. Nachamkin  I, Arzarte Barbosa  P, Ung  H, Lobato  C, Gonzalez Rivera  A, Rodriguez  P, et al. Patterns of Guillain-Barre syndrome in children: results from a Mexican population. Neurology. 2007;69:1665–71. DOIPubMedGoogle Scholar
  5. Sejvar  JJ, Kohl  KS, Gidudu  J, Amato  A, Bakshi  N, Baxter  R, et al.; Brighton Collaboration GBS Working Group. Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2011;29:599–612. DOIPubMedGoogle Scholar
  6. Lior  H. New, extended biotyping scheme for Campylobacter jejuni, Campylobacter coli, and “Campylobacter laridis”. J Clin Microbiol. 1984;20:636–40. DOIPubMedGoogle Scholar
  7. Hughes  RA, Cornblath  DR. Guillain-Barré syndrome. Lancet. 2005;366:1653–66. DOIPubMedGoogle Scholar
  8. Hughes  RA, Rees  JH. Clinical and epidemiologic features of Guillain-Barré syndrome. J Infect Dis. 1997;176(Suppl 2):S92–8. DOIPubMedGoogle Scholar
  9. Zhang  M, He  L, Li  Q, Sun  H, Gu  Y, You  Y, et al. Genomic characterization of the Guillain-Barre syndrome-associated Campylobacter jejuni ICDCCJ07001 Isolate. PLoS One. 2010;5:e15060. DOIPubMedGoogle Scholar
  10. Zhang  M, Li  Q, He  L, Meng  F, Gu  Y, Zheng  M, et al. Association study between an outbreak of Guillain-Barre syndrome in Jilin, China, and preceding Campylobacter jejuni infection. Foodborne Pathog Dis. 2010;7:913–9. DOIPubMedGoogle Scholar

Main Article

Page created: August 25, 2020
Page updated: October 19, 2020
Page reviewed: October 19, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external